Growth Metrics

Nutex Health (NUTX) Gross Profit (2017 - 2026)

Nutex Health (NUTX) has disclosed Gross Profit for 17 consecutive years, with $91.7 million as the latest value for Q1 2026.

  • For Q1 2026, Gross Profit fell 22.48% year-over-year to $91.7 million; the TTM value through Mar 2026 reached $417.7 million, up 37.19%, while the annual FY2025 figure was $444.3 million, 126.37% up from the prior year.
  • Gross Profit hit $91.7 million in Q1 2026 for Nutex Health, up from $46.1 million in the prior quarter.
  • Across five years, Gross Profit topped out at $154.9 million in Q3 2025 and bottomed at -$26.5 million in Q3 2022.
  • Average Gross Profit over 5 years is $46.1 million, with a median of $21.9 million recorded in 2024.
  • On a YoY basis, Gross Profit climbed as much as 8290.22% in 2022 and fell as far as 134.82% in 2022.
  • Nutex Health's Gross Profit stood at $530324.0 in 2022, then surged by 2391.55% to $13.2 million in 2023, then soared by 971.84% to $141.6 million in 2024, then plummeted by 67.42% to $46.1 million in 2025, then skyrocketed by 98.82% to $91.7 million in 2026.
  • According to Business Quant data, Gross Profit over the past three periods came in at $91.7 million, $46.1 million, and $154.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.